Annual Accounts Payable
$2.41 M
-$1.37 M-36.27%
December 31, 2022
Summary
- As of February 10, 2025, RVLP annual accounts payable is $2.41 million, with the most recent change of -$1.37 million (-36.27%) on December 31, 2022.
- During the last 3 years, RVLP annual accounts payable has fallen by -$6.09 million (-71.67%).
Performance
RVLP Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Payable
$2.53 M
-$100.00 K-3.80%
June 30, 2023
Summary
- As of February 10, 2025, RVLP quarterly accounts payable is $2.53 million, with the most recent change of -$100.00 thousand (-3.80%) on June 30, 2023.
- Over the past year, RVLP quarterly accounts payable has dropped by -$2.91 million (-53.47%).
Performance
RVLP Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
RVLP Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -36.3% | -53.5% |
| 3 y3 years | -71.7% | -71.2% |
| 5 y5 years | -93.3% | -92.2% |
RVLP Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -36.3% | at low | -63.9% | -4.9% |
| 5 y | 5-year | -71.7% | at low | -71.2% | -38.8% |
| alltime | all time | -93.3% | at low | -93.0% | -38.8% |
RVL Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $2.53 M(-3.8%) |
| Mar 2023 | - | $2.63 M(+9.3%) |
| Dec 2022 | $2.41 M(-36.3%) | $2.41 M(-65.6%) |
| Sep 2022 | - | $7.00 M(+28.8%) |
| Jun 2022 | - | $5.44 M(+14.9%) |
| Mar 2022 | - | $4.73 M(+25.3%) |
| Dec 2021 | $3.78 M(+20.7%) | $3.78 M(-15.1%) |
| Sep 2021 | - | $4.45 M(+187.2%) |
| Jun 2021 | - | $1.55 M(-65.7%) |
| Mar 2021 | - | $4.52 M(+44.6%) |
| Dec 2020 | $3.13 M | $3.13 M(-60.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $7.91 M(-10.1%) |
| Jun 2020 | - | $8.80 M(+0.2%) |
| Mar 2020 | - | $8.78 M(+3.4%) |
| Dec 2019 | $8.49 M(-65.8%) | $8.49 M(-14.2%) |
| Sep 2019 | - | $9.91 M(-47.6%) |
| Jun 2019 | - | $18.92 M(-8.1%) |
| Mar 2019 | - | $20.59 M(-17.2%) |
| Dec 2018 | $24.87 M(-31.0%) | $24.87 M(-10.7%) |
| Sep 2018 | - | $27.86 M(-14.4%) |
| Jun 2018 | - | $32.55 M(-9.7%) |
| Dec 2017 | $36.07 M(+3.1%) | $36.07 M |
| Dec 2016 | $34.98 M | - |
FAQ
- What is RVL Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for RVL Pharmaceuticals?
- What is RVL Pharmaceuticals annual accounts payable year-on-year change?
- What is RVL Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for RVL Pharmaceuticals?
- What is RVL Pharmaceuticals quarterly accounts payable year-on-year change?
What is RVL Pharmaceuticals annual accounts payable?
The current annual accounts payable of RVLP is $2.41 M
What is the all time high annual accounts payable for RVL Pharmaceuticals?
RVL Pharmaceuticals all-time high annual accounts payable is $36.07 M
What is RVL Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, RVLP annual accounts payable has changed by -$1.37 M (-36.27%)
What is RVL Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of RVLP is $2.53 M
What is the all time high quarterly accounts payable for RVL Pharmaceuticals?
RVL Pharmaceuticals all-time high quarterly accounts payable is $36.07 M
What is RVL Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, RVLP quarterly accounts payable has changed by -$2.91 M (-53.47%)